After two years of research, field experimentation, and collaboration with veterinarians, the French company Invoxia is set to launch its Biotracker GPS, a next-generation sensor designed for canine well-being.
Amazon co-founder MacKenzie Scott has donated over $19 billion to charity in just five years
Diamond batteries powered by nuclear waste promise 28,000 years of clean energy
A Holistic Approach to Dog Health
Similar to the Minitailz, the Biotracker GPS operates at the intersection of smart GPS tracking, activity monitoring, and physiological health surveillance. This new, lightweight device (weighing just 37 grams) can be attached to any collar and extends far beyond the capabilities of traditional activity trackers.
The Biotracker GPS will enable real-time tracking of a dog’s location, measure daily activity (including walking, running, resting times, bark detection, etc.), analyze heart and respiratory rates during rest periods, and send smart health alerts in case of any abnormalities.
Thanks to its connectivity and a dedicated app, the collected data can be easily shared with veterinarians, providing better insights into the pet’s overall health between visits. Veterinary professionals, especially those working with more sensitive breeds, have shown a positive reception to such devices, as seen with the Minitailz.
Embedded Veterinary AI Technology
The technology behind this compact sensor is powered by artificial intelligence developed in collaboration with the Veterinary School of Maisons-Alfort and Cornell University in the United States. This AI is capable of detecting subtle signs that might go unnoticed by the human eye, such as stress, unusual sedentariness, or physiological changes. It can even assess the risk of atrial fibrillation (AFib), a typically silent cardiac disorder, particularly in certain small dog breeds like the Cavalier King Charles Spaniel or the French Bulldog.
However, it is important to note that the Biotracker GPS is not a medical device. Invoxia markets it as a connected wellness assistant, designed for daily use by pet owners, and not as a diagnostic tool. The goal is to provide early warnings rather than cures, quickly informing owners of significant behavioral or physiological changes.
With this launch, Invoxia confirms its pioneering role in the European market for connected pet devices and lays the groundwork for a new generation of smart sensors for pets, combining technology, health, and prevention. It’s a promising tool that is worth keeping an eye on.
Currently in the beta testing phase, the INVOXIA Biotracker GPS will be available for purchase starting in July at a price of €149 (including the device and a 12-month subscription), initially exclusively on invoxia.com during the launch period, and later on Amazon, through veterinarians, and in specialized pet and tech retail stores, both in France and internationally.